June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Smartphone Application- and Paper-Based Patient-Reported Outcomes Using a Disease-Specific Questionnaire for Dry Eye Disease: A Randomized Cross-Over Equivalence Study
Author Affiliations & Notes
  • Ken Nagino
    Opthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Hospital Administration, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Alan Yee
    Opthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Yuichi Okumura
    Opthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Kenta Fujio
    Opthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Yasutsugu Akasaki
    Opthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Akie Midorikawa-Inomata
    Hospital Administration, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Atsuko Eguchi
    Hospital Administration, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Kunihiko Hirosawa
    Opthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Tianxiang Huang
    Opthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Takenori Inomata
    Opthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Ken Nagino InnoJin Inc., Code E (Employment), InnoJin Inc., Code S (non-remunerative); Alan Yee None; Yuichi Okumura InnoJin, Inc., Code E (Employment), Johnson & Johnson.,FUKOKU Co., Ltd., Code F (Financial Support), InnoJin, Inc., Code P (Patent); Kenta Fujio None; Yasutsugu Akasaki None; Akie Midorikawa-Inomata None; Atsuko Eguchi None; Kunihiko Hirosawa None; Tianxiang Huang None; Takenori Inomata Santen Pharmaceutical Co., Ltd., Code C (Consultant/Contractor), InnoJin, Inc., Code E (Employment), Novartis Pharma KK, Santen Pharmaceutical Co., Ltd., Lion Corporation, SEED Co., Ltd., Johnson & Johnson, Shin Nippon Biomedical Laboratories, Ltd., IBM Japan, Ltd., Code F (Financial Support), Renatech Co., Ltd., InnoJin Inc., Code P (Patent)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3998. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ken Nagino, Alan Yee, Yuichi Okumura, Kenta Fujio, Yasutsugu Akasaki, Akie Midorikawa-Inomata, Atsuko Eguchi, Kunihiko Hirosawa, Tianxiang Huang, Takenori Inomata; Smartphone Application- and Paper-Based Patient-Reported Outcomes Using a Disease-Specific Questionnaire for Dry Eye Disease: A Randomized Cross-Over Equivalence Study. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3998.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Smartphone application-based patient-reported outcomes may be useful for early diagnosis, prompt intervention, and continuous monitoring for dry eye disease (DED). However, a comprehensive evaluation and comparison of the smartphone application- and paper-based patient-reported outcomes is warranted to assess the equivalency of the two platforms. We performed the prospective, non-blinded, randomized cross-over study to assess the equivalence between a smartphone application- and paper-based questionnaires for DED.

Methods : In this study, we recruited 34 participants aged ≥20 years between April and June 2022, at a university hospital in Japan. Patients with any missing data were excluded from the analysis. The equivalence test based on minimal clinically important difference (MCID) was used to assess the equivalence of the Japanese version of the Ocular Surface Disease Index (J-OSDI) total scores between two platforms. Equivalence was determined if the 95% confidence interval (CI) of the mean difference between total scores of the application- and paper-based J-OSDI was within the ± 7.0 range. Reliability of the application- based J-OSDI was evaluated using Cronbach’s alpha and intraclass correlation coefficients. The correlation between the application- and paper-based J-OSDIs was assessed using Pearson correlation coefficient.

Results : In total, 33 participants were included. One patient was excluded due to missing data due to poor internet connection. The application- and paper-based J-OSDI total scores were equivalent (mean difference, 1.8, 95% CI, -1.4 to 5.0). The application-based J-OSDI total score showed good internal consistency and agreement (Cronbach’s alpha coefficient = 0.958, intraclass correlation coefficient = 0.919) and was significantly correlated with the paper-based J-OSDI total score (Pearson correlation coefficient = 0.932).

Conclusions : This study demonstrated the equivalence of patient-reported outcomes between the application- and paper-based J-OSDI. Implementing the application-based J-OSDI as a tool for mobile health management of DED could have implications for the early diagnosis of DED and longitudinal patient-reported outcomes monitoring.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×